IDL Biotech

ISIN SE0012193340Filings at the FI

At a glance

Most recent filing on October 26, 2020 — an open-market purchase by Gunnar Vahlberg on Oct 23, 2020.

We hold 1 visible filing, going back to October 23, 2020.

Filings we could not classify with confidence are set aside for review, so they are in none of these counts.

All 1 shown